Key facts
- Notable investors include Oriental Fortune Capital, Kangyu Capital, U.O. Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Angio8
- ·The full record, as it builds
Funding rounds
No funding rounds for Angio8 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Angio8
Manufacturer of vascular interventional surgical robots intended to serve the medical industry. The company is primarily focused on clinical robots for vascular interventional surgery, with strict production and operational management, thereby enabling the provision of high-quality clinical and surgical robots to clients.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2021
- Website
- angio8.com/
- Ownership
- Privately Held (backing)
Angio8 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Angio8 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Angio8 in its N-PORT filings yet. We sweep new filings monthly.